29 July 2024 in Advances in Biochemistry
The Triglyceride-Glucose (TyG) index is a marker used to assess insulin resistance which is associated with the occurrence of gestational diabetes. The aim of this study is to determine the benefit of the TyG within the diagnosis of insulin resistance in pregnant women in an orally induced hyperglycaemia test. This study was conducted at the Department of Biochemistry, at Aristide le Dantec University Hospital in collaboration with the department of gynaecology. Women with fasting blood glucose < 0.92 g/L at 12 weeks of age benefited from the OGTT 75 test following the WHO protocol. The TyG index was calculated using the formula: Ln [fasting triglyceridemia (mg/dL) × fasting blood glucose (mg/dL)]/2. Data were analysed using SPSS v.26 and a p< value of 0.05 was considered statistically significant. A total of 102 patients were included in the study with a mean age of 29± to 5.9 years. The OGTT 75 test was positive in 24 women (23.5%) with a predominance in the third trimester (19.4%). TyG values were significantly higher in women with gestational diabetes (8.76, ±0.5vs8.2±, 0.5; p<0.0001), in contrast to the HOMA index (6.43, ±16.8, ±1.15±, 0.9; p=0.138). The AUC of the ROC curve for the TyG-H0, TyG-H1 and TyG-H2 indices were 0.808 (95% CI)=0.70-0.92), 0.808 (95% CI)=0.698-0.918), 0.818 (95% CI)=0.70-0.93, respectively. For the HOMA-IR index, the AUC was 0.799 (95% CI = 0.69-0.91). The cut-off value for the TyG-H 1 index was 9.5 with a sensitivity and specificity of 79.2% and 71.8%, respectively. The TyG index is a better way to assess the level of insulin resistance in pregnant women than using the HOMA index, especially after the first hour of a glucose load of 75g.
18 October 2024 in Advances in Biochemistry
Diabetes is a metabolic disease characterized by chronic hyperglycemia resulting from a defect in insulin secretion and/or insulin action. When not well controlled, it leads to long-term microangiopathic complications, including diabetic nephropathy. Against this backdrop, we set out to evaluate microalbuminuria and the clinical and biological factors associated with it in subjects with type 2 diabetes. This is a prospective, descriptive study including type 2 diabetic patients well followed at the Mark Sankale Center of the Abass Ndao Hospital in Dakar. Biochemical parameters (microalbuminuria, lipid profile, glycated hemoglobin and fasting blood glucose) were measured using enzymatic techniques with the Cobas 6000/c501® system (Roche, Hitachi, Germany). XLSTAT software was used to evaluate the data, and a value of p<0.05 was considered a statistically significant difference. A total of 166 diabetic patients with a mean age of 54 ±13.9 years and a sex ratio of 0.50 were included in our study. Microalbuminuria was present in 40.36% of the study population. Among patients with unbalanced diabetes, 50.74% had positive microalbuminuria. When hypertension was associated with diabetes, microalbuminuria was positive in 61.19% of patients. In terms of dyslipidemia, hypercholesterolemia was the only abnormality significantly associated with microalbuminuria (p<0.001). Microalbuminuria is an essential parameter in the detection of diabetic nephropathy. In our study, its occurrence was associated with several abnormalities, including unbalanced diabetes, hypertension and hypercholesterolemia.